Lnc ing epigenetic control of transcription to cardiovascular development and disease

Circulation Research

Volumn 117, Issue 2, 2015, Pages 192-206

  Rizki, Gizem ^a   Boyer, Laurie A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cardiovascular disease; epigenomics; homeostasis; long noncoding RNA

Indexed keywords

BIOLOGICAL MARKER; HISTONE; LONG UNTRANSLATED RNA; MICRORNA; TRANSCRIPTION FACTOR; TRANSCRIPTOME; VOLTAGE GATED POTASSIUM CHANNEL;

AORTA VALVE; AORTA VALVE CALCIFICATION; AORTA VALVE DISEASE; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENHANCER REGION; EPIGENETICS; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC RISK; GENOME; HEART; HEART DEVELOPMENT; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM DEFECT; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; ANIMAL; CARDIOVASCULAR SYSTEM; CLASSIFICATION; EMBRYOLOGY; FETUS HEART; FORECASTING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART SEPTUM DEFECT; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; FETAL HEART; FORECASTING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEART SEPTAL DEFECTS, VENTRICULAR; HISTONES; HUMANS; MICE; MICRORNAS; MYOCYTES, CARDIAC; RNA, LONG NONCODING; TRANSCRIPTION, GENETIC;

EID: 84937710173     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.304156     Document Type: Review

References (148)

1. Bruneau BG. Signaling and transcriptional networks in heart development and regeneration. Cold Spring Harb Perspect Biol. 2013; 5: a008292. doi: 10.1101/cshperspect.a008292
2. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science (80-). 2006; 313: 1922-1927. http://www.ncbi.nlm.nih. gov/pubmed/17008524
3. Wamstad JA, Alexander JM, Truty RM, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell. 2012; 151: 206-220. doi: 10.1016/j.cell.2012.07.035
4. O'Meara C, Wamstad JA, Gladstone R, Fomovsky G, Butty V, Shrikumar A, Gannon J, Boyer L, Lee RT. Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. Circ Res. 2014. doi: CIRCRESAHA.116.304269 [pii] 10.1161/CIRCRESAHA.116.304269
5. Gilsbach R, Preissl S, Grüning BA, Schnick T, Burger L, Benes V, Würch A, Bönisch U, Günther S, Backofen R, Fleischmann BK, Schübeler D, Hein L. Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease. Nat Commun. 2014; 5: 5288. doi: 10.1038/ncomms6288
6. Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010; 122: 2727-2735. doi: 10.1161/CIRCULATIONAHA.110.942268
7. Dirkx E, da Costa Martins PA, De Windt LJ. Regulation of fetal gene expression in heart failure. Biochim Biophys Acta. 2013; 1832: 2414-2424. doi: 10.1016/j.bbadis.2013.07.023
8. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003; 65: 45-79. doi: 10.1146/annurev. physiol.65.092101.142243
9. Kim Y, Phan D, van Rooij E, Wang DZ, McAnally J, Qi X, Richardson JA, Hill JA, Bassel-Duby R, Olson EN. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest. 2008; 118: 124-132. doi: 10.1172/JCI33255
10. Carninci P, Kasukawa T, Katayama S, et al; FANTOM Consortium; RIKEN Genome Exploration Research Group and Genome Science Group (Genome Network Project Core Group). The transcriptional landscape of the mammalian genome. Science. 2005; 309: 1559-1563. doi: 10.1126/science.1112014
11. David L, Huber W, Granovskaia M, Toedling J, Palm CJ, Bofkin L, Jones T, Davis RW, Steinmetz LM. A high-resolution map of transcription in the yeast genome. Proc Natl Acad Sci USA 2006; 103: 5320-5325. doi: 10.1073/pnas.0601091103
12. Stolc V, Gauhar Z, Mason C, Halasz G, van Batenburg MF, Rifkin SA, Hua S, Herreman T, Tongprasit W, Barbano PE, Bussemaker HJ, White KP. A gene expression map for the euchromatic genome of Drosophila melanogaster. Science. 2004; 306: 655-660. doi: 10.1126/science.1101312
13. Li L, Wang X, Stolc V, Li X, Zhang D, Su N, Tongprasit W, Li S, Cheng Z, Wang J, Deng XW. Genome-wide transcription analyses in rice using tiling microarrays. Nat Genet. 2006; 38: 124-129. doi: 10.1038/ng1704
14. Lu ZJ, Yip KY, Wang G, et al. Prediction and characterization of noncoding RNAs in C. elegans by integrating conservation, secondary structure, and high-throughput sequencing and array data. Genome Res. 2011; 21: 276-285. doi: 10.1101/gr.110189.110
15. Flicek P, Amode MR, Barrell D, et al. Ensembl 2014. Nucleic Acids Res. 2014; 42: D749-D755. doi: 10.1093/nar/gkt1196
16. Guttman M, Russell P, Ingolia NT, Weissman JS, Lander ES. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell. 2013; 154: 240-251. doi: 10.1016/j.cell.2013.06.009
17. Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22: 1775-1789. doi: 10.1101/gr.132159.111
18. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25: 1915-1927. doi: 10.1101/gad.17446611
19. Uchida S, Dimmeler S. Long noncoding RNAs in cardiovascular diseases. Circ Res. 2015; 116: 737-750. doi: 10.1161/CIRCRESAHA.116.302521
20. Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013; 10: 925-933. doi: 10.4161/rna.24604
21. Bu D, Yu K, Sun S, et al. NONCODE v3.0: Integrative annotation of long noncoding RNAs. Nucleic Acids Res. 2012; 40: 210-215. doi: 10.1093/nar/gkr1175
22. St. Laurent G, Wahlestedt C, Kapranov P. The Landscape of long noncoding RNA classification. Trends Genet. 2015; 31: 239-251. doi: 10.1016/j. tig.2015.03.007
23. Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154: 26-46. doi: 10.1016/j.cell.2013.06.020
24. Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013; 20: 300-307. doi: 10.1038/nsmb.2480
25. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012; 81: 145-166. http://www.annualreviews.org/doi/abs/10.1146/annurev-biochem-051410-092902
26. Rinn JL. lncRNAs: linking RNA to chromatin. Cold Spring Harb Perspect Biol. 2014; 6. doi: 10.1101/cshperspect.a018614
27. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013; 152: 1298-1307. doi: 10.1016/j. cell.2013.02.012
28. Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N. Requirement for Xist in X chromosome inactivation. Nature. 1996; 379: 131-137. doi: 10.1038/379131a0
29. Pauli A, Rinn JL, Schier AF. Non-coding RNAs as regulators of embryogenesis. Nat Rev Genet. 2011; 12: 136-149. doi: 10.1038/nrg2904
30. Bao J, Wu J, Schuster AS, Hennig GW, Yan W. Expression profiling reveals developmentally regulated lncRNA repertoire in the mouse male germline. Biol Reprod. 2013; 89: 107. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrievedb=PubMeddopt=Citationlist-uids=24048575
31. Sauvageau M, Goff LA, Lodato S, et al. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife. 2013; 2: e01749. doi: 10.7554/eLife.01749
32. Kretz M, Siprashvili Z, Chu C, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2013; 493: 231-235. http://www.ncbi.nlm.nih.gov/pubmed/23201690
33. Hu W, Alvarez-Dominguez JR, Lodish HF. Regulation of mammalian cell differentiation by long non-coding RNAs. EMBO Rep. 2012; 13: 971-983. doi: 10.1038/embor.2012.145
34. Guttman M, Donaghey J, Carey BW, et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature. 2011; 477: 295-300. http://www.ncbi.nlm.nih.gov/pubmed/21874018
35. Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A, Prasanth K V. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013; 9: e1003368.
36. Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci. 2013; 70: 4785-4794. doi: 10.1007/s00018-013-1423-0
37. Kornfeld JW, Brüning JC. Regulation of metabolism by long, non-coding RNAs. Front Genet. 2014; 5: 57. doi: 10.3389/fgene.2014.00057
38. Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21: 354-361. doi: 10.1016/j.tcb.2011.04.001
39. Jacob MD, Audas TE, Uniacke J, Trinkle-Mulcahy L, Lee S. Environmental cues induce a long noncoding RNA-dependent remodeling of the nucleolus. Mol Biol Cell. 2013; 24: 2943-2953. doi: 10.1091/mbc.E13-04-0223
40. Xing Z, Lin A, Li C, Liang K, Wang S, Liu Y, Park PK, Qin L, Wei Y, Hawke DH, Hung MC, Lin C, Yang L. lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell. 2014; 159: 1110-1125. doi: 10.1016/j.cell.2014.10.013
41. Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43: 904-914. http://linkinghub.elsevier.com/retrieve/pii/S1097276511006368
42. ørom UA, Shiekhattar R. Long non-coding RNAs and enhancers. Curr Opin Genet Dev. 2011; 21: 194-198. doi: 10.1016/j.gde.2011.01.020
43. Mattick JS. Linc-ing long noncoding RNAs and enhancer function. Dev Cell. 2010; 19: 485-486. doi: 10.1016/j.devcel.2010.10.003
44. Kim T, Hemberg M, Gray JM. Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers. Cold Spring Harb Perspect Biol. 2015; 7: a018622. doi: 10.1101/cshperspect.a018622
45. Ng SY, Johnson R, Stanton LW. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. EMBO J. 2012; 31: 522-533. http://www.ncbi.nlm.nih.gov/pubmed/22193719
46. Grote P, Wittler L, Hendrix D, Koch F, Währisch S, Beisaw A, Macura K, Bläss G, Kellis M, Werber M, Herrmann BG. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013; 24: 206-214. doi: 10.1016/j.devcel.2012.12.012
47. Klattenhoff CA, Scheuermann JC, Surface LE, et al. Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell. 2013; 152: 570-583. doi: S0092-8674(13)00004-4 [pii] 10.1016/j.cell.2013.01.003
48. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011; 147: 358-369. doi: 10.1016/j.cell.2011.09.028
49. Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, Wu M, Xiong J, Guo X, Liu H. Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013; 25: 69-80. doi: 10.1016/j.devcel.2013.03.002
50. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, Blencowe BJ, Prasanth SG, Prasanth KV. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010; 39: 925-938. doi: 10.1016/j.molcel.2010.08.011
51. Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature. 2011; 470: 284-288. doi: 10.1038/nature09701
52. Yoon JH, Abdelmohsen K, Srikantan S, Yang X, Martindale JL, De S, Huarte M, Zhan M, Becker KG, Gorospe M. LincRNA-p21 suppresses target mRNA translation. Mol Cell. 2012; 47: 648-655. doi: 10.1016/j. molcel.2012.06.027
53. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell. 2006; 126: 1037-1048. http://www.ncbi.nlm.nih.gov/pubmed/16990131
54. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008; 132: 661-680. doi: 10.1016/j.cell.2008.02.008
55. Evans SM, Yelon D, Conlon FL, Kirby ML. Myocardial lineage development. Circ Res. 2010; 107: 1428-1444. http://www.ncbi.nlm.nih.gov/pubmed/21148449
56. Bruneau BG. The developmental genetics of congenital heart disease. Nature. 2008; 451: 943-948. http://www.ncbi.nlm.nih.gov/pubmed/18288184
57. Zhu S, Hu X, Han S, Yu Z, Peng Y, Zhu J, Liu X, Qian L, Zhu C, Li M, Song G, Guo X. Differential expression profile of long non-coding RNAs during differentiation of cardiomyocytes. Int J Med Sci. 2014; 11: 500-507. doi: 10.7150/ijms.7849
58. Zhu JG, Shen YH, Liu HL, Liu M, Shen YQ, Kong XQ, Song GX, Qian LM. Long noncoding RNAs expression profile of the developing mouse heart. J Cell Biochem. 2014; 115: 910-918. doi: 10.1002/jcb.24733
59. Matkovich SJ, Edwards JR, Grossenheider TC, de Guzman Strong C, Dorn GW II. Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc Natl Acad Sci USA 2014; 111: 12264-12269. doi: 10.1073/pnas.1410622111
60. Bondue A, Tännler S, Chiapparo G, Chabab S, Ramialison M, Paulissen C, Beck B, Harvey R, Blanpain C. Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation. J Cell Biol. 2011; 192: 751-765. doi: 10.1083/jcb.201007063
61. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M, Blanpain C. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell. 2008; 3: 69-84. doi: 10.1016/j. stem.2008.06.009
62. Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011; 469: 343-349. doi: 10.1038/nature09784
63. Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol. 2009; 10: 697-708. doi: 10.1038/nrm2763
64. Delgado-Olguín P, Huang Y, Li X, Christodoulou D, Seidman CE, Seidman JG, Tarakhovsky A, Bruneau BG. Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis. Nat Genet. 2012; 44: 343-347. doi: 10.1038/ng.1068
65. He A, Ma Q, Cao J, et al. Polycomb repressive complex 2 regulates normal development of the mouse heart. Circ Res. 2012; 110: 406-415. doi: 10.1161/CIRCRESAHA.111.252205
66. Bell RD, Long X, Lin M, Bergmann JH, Nanda V, Cowan SL, Zhou Q, Han Y, Spector DL, Zheng D, Miano JM. Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol. 2014; 34: 1249-1259. doi: 10.1161/ATVBAHA.114.303240
67. Thum T, Kumarswamy R. The smooth long noncoding RNA SENCR. Arterioscler Thromb Vasc Biol. 2014; 34: 1124-1125. doi: 10.1161/ATVBAHA.114.303504
68. Liu F, Walmsley M, Rodaway A, Patient R. Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol. 2008; 18: 1234-1240. doi: 10.1016/j.cub.2008.07.048
69. Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W, Uchida S, Boon RA, Dimmeler S. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014; 114: 1389-1397. doi: 10.1161/CIRCRESAHA.114.303265
70. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003; 22: 8031-8041. doi: 10.1038/sj.onc.1206928
71. Yang L, Lin C, Liu W, Zhang J, Ohgi KA, Grinstein JD, Dorrestein PC, Rosenfeld MG. ncRNA-and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell. 2011; 147: 773-788. doi: 10.1016/j.cell.2011.08.054
72. Thum T, Fiedler J. LINCing MALAT1 and angiogenesis. Circ Res. 2014; 114: 1366-1368. doi: 10.1161/CIRCRESAHA.114.303896
73. Eismann M, Gutschner T, Hämmerle M, Günther S, Caudron-Herger M, Gros M, Schirmacher P, Rippe K, Braun T, Zörnig M, Diederichs S. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol. 2012; 9: 1076-1087. doi: 10.4161/rna.21089
74. Zhang B, Arun G, Mao YS, Lazar Z, Hung G, Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C, Spector DL. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012; 2: 111-123. doi: S2211-1247(12)00163-5 [pii] 10.1016/j.celrep.2012.06.003
75. Sadowski SL. Congenital cardiac disease in the newborn infant: past, present, and future. Crit Care Nurs Clin North Am. 2009; 21: 37-48, vi. doi: 10.1016/j.ccell.2008.10.001
76. Song G, Shen Y, Zhu J, Liu H, Liu M, Shen YQ, Zhu S, Kong X, Yu Z, Qian L. Integrated analysis of dysregulated lncRNA expression in fetal cardiac tissues with ventricular septal defect. PLoS One. 2013; 8: e77492. doi: 10.1371/journal.pone.0077492
77. Nanni L, Romualdi C, Maseri A, Lanfranchi G. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. J Mol Cell Cardiol. 2006; 41: 934-948. doi: 10.1016/j.yjmcc.2006.08.009
78. Lee JH, Gao C, Peng G, Greer C, Ren S, Wang Y, Xiao X. Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res. 2011; 109: 1332-1341. doi: 10.1161/CIRCRESAHA.111.249433
79. Liu H, Song G, Zhou L, Hu X, Liu M, Nie J, Lu S, Wu X, Cao Y, Tao L, Chen L, Qian L. Compared analysis of LncRNA expression profiling in pdk1 gene knockout mice at two time points. Cell Physiol Biochem. 2013; 32: 1497-1508. doi: 10.1159/000356586
80. Mora A, Davies AM, Bertrand L, Sharif I, Budas GR, Jovanović S, Mouton V, Kahn CR, Lucocq JM, Gray GA, Jovanović A, Alessi DR. Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J. 2003; 22: 4666-4676. doi: 10.1093/emboj/cdg469
81. Di RM, Feng QT, Chang Z, Luan Q, Zhang YY, Huang J, Li XL, Yang ZZ. PDK1 plays a critical role in regulating cardiac function in mice and human. Chin Med J. 2010; 123: 2358-2363. http://www.ncbi.nlm.nih. gov/entrez/query.fcgi?cmd=Retrievedb=PubMeddopt=Citationli st-uids=21034549
82. Yang KC, Yamada KA, Patel AY, Topkara VK, George I, Cheema FH, Ewald GA, Mann DL, Nerbonne JM. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014; 129: 1009-1021. doi: 10.1161/CIRCULATIONAHA.113.003863
83. Li D, Chen G, Yang J, Fan X, Gong Y, Xu G, Cui Q, Geng B. Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure. PLoS One. 2013; 8: e77938. doi: 10.1371/journal.pone.0077938 PONE-D-13-21514 [pii
84. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, Lemesle G, de Groote P, Pinet F, Thum T. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res. 2014; 114: 1569-1575. doi: 10.1161/CIRCRESAHA.114.303915
85. Ounzain S, Micheletti R, Beckmann T, et al. Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heartspecific long non-coding RNAs. Eur Hear J. 2014. doi: 10.1093/eurheartj/ehu180
86. Liu Y, Li G, Lu H, Li W, Li X, Liu H, Li T, Yu B. Expression profiling and ontology analysis of long noncoding RNAs in post-ischemic heart and their implied roles in ischemia/reperfusion injury. Gene. 2014; 543: 15-21. doi: S0378-1119(14)00416-8 [pii] 10.1016/j.gene.2014.04.016
87. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008; 358: 1370-1380. doi: 10.1056/NEJMra072139
88. Jiang XY, Ning QL. Expression profiling of long noncoding RNAs and the dynamic changes of lncRNA-NR024118 and Cdkn1c in angiotensin II-treated cardiac fibroblasts. Int J Clin Exp Pathol. 2014; 7: 1325-1336. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve& db=PubM ed& dopt=Citation& list-uids=24817929
89. Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by angiotensin II. Methods Find Exp Clin Pharmacol. 2000; 22: 709-723. doi: 802287 [pii
90. Ward C. Clinical significance of the bicuspid aortic valve. Heart. 2000; 83: 81-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Ret rieve& db=PubMed& dopt=Citation& list-uids=10618341
91. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005; 111: 3316-3326. doi: 10.1161/CIRCULATIONAHA.104.486738
92. Carrion K, Dyo J, Patel V, Sasik R, Mohamed SA, Hardiman G, Nigam V. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS One. 2014; 9: e96577. doi: 10.1371/journal. pone.0096577
93. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007; 129: 1311-1323. doi: 10.1016/j. cell.2007.05.022
94. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464: 1071-1076. doi: 10.1038/nature08975
95. ENCODE project consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489: 57-74. doi: nature11247 [pii] 10.1038/nature11247
96. Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, Blow MJ, Cohen JC, Rubin EM, Pennacchio LA. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature. 2010; 464: 409-412. doi: 10.1038/nature08801
97. Brunner AL, Beck AH, Edris B, et al. Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers. Genome Biol. 2012; 13: R75. doi: 10.1186/gb-2012-13-8-r75
98. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007; 316: 1491-1493. doi: 10.1126/science.1142842
99. Broadbent HM, Peden JF, Lorkowski S, et al; PROCARDIS consortium. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet. 2008; 17: 806-814. doi: 10.1093/hmg/ddm352
100. Folkersen L, Kyriakou T, Goel A, Peden J, Mälarstig A, Paulsson-Berne G, Hamsten A, Hugh Watkins, Franco-Cereceda A, Gabrielsen A, Eriksson P; PROCARDIS consortia. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One. 2009; 4: e7677. doi: 10.1371/journal. pone.0007677
101. Holdt LM, Beutner F, Scholz M, Gielen S, Gäbel G, Bergert H, Schuler G, Thiery J, Teupser D. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol. 2010; 30: 620-627. doi: 10.1161/ATVBAHA.109.196832
102. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38: 662-674. doi: 10.1016/j.molcel.2010.03.021
103. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, Frazer KA. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature. 2011; 470: 264-268. doi: 10.1038/nature09753
104. Ishii N, Ozaki K, Sato H, Mizuno H, Saito S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, Saito S, Nakamura Y, Tanaka T. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet. 2006; 51: 1087-1099. doi: 10.1007/s10038-006-0070-9
105. Sone M, Hayashi T, Tarui H, Agata K, Takeichi M, Nakagawa S. The mRNA-like noncoding RNA Gomafu constitutes a novel nuclear domain in a subset of neurons. J Cell Sci. 2007; 120: 2498-2506. doi: 10.1242/jcs.009357
106. Rapicavoli NA, Poth EM, Blackshaw S. The long noncoding RNA RNCR2 directs mouse retinal cell specification. BMC Dev Biol. 2010; 10: 49. doi: 10.1186/1471-213X-10-49
107. Sheik Mohamed J, Gaughwin PM, Lim B, Robson P, Lipovich L. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells. RNA. 2010; 16: 324-337. doi: 10.1261/rna.1441510
108. Yan B, Liu J, Yao J, Li X, Wang X, Li Y, Tao Z, Song Y, Chen Q, Jiang Q. LncRNA-MIAT Regulates Microvascular Dysfunction by Functioning as a Competing Endogenous RNA. Circ Res. 2015. doi: CIRCRESAHA.116.305510 [pii] 10.1161/CIRCRESAHA.116.305510
109. Colley SM, Leedman PJ. Steroid Receptor RNA Activator -A nuclear receptor coregulator with multiple partners: insights and challenges. Biochimie. 2011; 93: 1966-1972. doi: 10.1016/j.biochi.2011.07.004
110. Cooper C, Vincett D, Yan Y, Hamedani MK, Myal Y, Leygue E. Steroid Receptor RNA Activator bi-faceted genetic system: Heads or Tails?. Biochimie. 2011; 93: 1973-1980. doi: 10.1016/j.biochi.2011.07.002
111. Friedrichs F, Zugck C, Rauch GJ, et al. HBEGF, SRA1, and IK: Three cosegregating genes as determinants of cardiomyopathy. Genome Res. 2009; 19: 395-403. doi: 10.1101/gr.076653.108
112. Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, Fuller-Pace FV, Hoffman EP, Tapscott SJ, Sartorelli V. The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev Cell. 2006; 11: 547-560. doi: 10.1016/j.devcel.2006.08.003
113. Quinodoz S, Guttman M. Long noncoding RNAs: an emerging link between gene regulation and nuclear organization. Trends Cell Biol. 2014; 24: 651-663. doi: 10.1016/j.tcb.2014.08.009
114. Brockdorff N. Noncoding RNA and Polycomb recruitment. RNA. 2013; 19: 429-442. doi: 10.1261/rna.037598.112
115. Grote P, Herrmann BG. The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis. RNA Biol. 2013; 10: 1579-1585. doi: 10.4161/rna.26165
116. Schuettengruber B, Martinez AM, Iovino N, Cavalli G. Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol. 2011; 12: 799-814. doi: 10.1038/nrm3230
117. Bassett AR, Akhtar A, Barlow DP, Bird AP, Brockdorff N, Duboule D, Ephrussi A, Ferguson-Smith AC, Gingeras TR, Haerty W, Higgs DR, Miska EA, Ponting CP. Considerations when investigating lncRNA function in vivo. Elife. 2014; 3: e03058. doi: 10.7554/eLife.03058
118. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E, Zhou B, Chang CP. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature. 2010; 466: 62-67. doi: 10.1038/nature09130
119. Han P, Li W, Lin CH, et al. A long noncoding RNA protects the heart from pathological hypertrophy. Nature. 2014.; 514: 102-106. doi: 10.1038/nature13596.http://www.ncbi.nlm.nih.gov/pubmed/25119045
120. Wang S, Zhang X, Yuan Y, Tan M, Zhang L, Xue X, Yan Y, Han L, Xu Z. BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro. Eur J Cardiothorac Surg. 2014. doi: ezu215 [pii] 10.1093/ejcts/ezu215
121. Korostowski L, Sedlak N, Engel N. The Kcnq1ot1 long non-coding RNA affects chromatin conformation and expression of Kcnq1, but does not regulate its imprinting in the developing heart. PLoS Genet. 2012; 8: e1002956. doi: 10.1371/journal.pgen.1002956
122. Harmer SC, Mohal JS, Royal AA, McKenna WJ, Lambiase PD, Tinker A. Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1. Biochem J. 2014; 462: 133-142. doi: 10.1042/BJ20140425
123. Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013; 52: 101-112. doi: 10.1016/j. molcel.2013.08.027
124. Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y, Guo J. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep. 2014; 4: 6088. doi: 10.1038/srep06088
125. Valdmanis PN, Kay MA. The expanding repertoire of circular RNAs. Mol Ther. 2013; 21: 1112-1114. doi: 10.1038/mt.2013.101
126. Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013; 495: 384-388. doi: 10.1038/nature11993
127. Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012; 7: e30733. doi: 10.1371/journal. pone.0030733
128. Wang K, Liu F, Zhou LY, Long B, Yuan SM, Wang Y, Liu CY, Sun T, Zhang XJ, Li PF. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res. 2014; 114: 1377-1388. doi: 10.1161/CIRCRESAHA.114.302476
129. Wang K, Long B, Zhou LY, Liu F, Zhou QY, Liu CY, Fan YY, Li PF. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun. 2014; 5: 3596. doi: 10.1038/ncomms4596
130. Engström PG, Suzuki H, Ninomiya N, et al. Complex Loci in human and mouse genomes. PLoS Genet. 2006; 2: e47. doi: 10.1371/journal. pgen.0020047
131. Anderson DM, Anderson KM, Bassel-duby R, Olson EN, Mcanally JR, Kasaragod P, Shelton JM, Liou J, Bassel-duby R, Olson EN. A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015; 160: 1-12. doi: 10.1016/j. cell.2015.01.009
132. Ulitsky I, Shkumatava A, Jan CH, Sive H, Bartel DP. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell. 2011; 147: 1537-1550. doi: 10.1016/j. cell.2011.11.055
133. Hezroni H, Koppstein D, Schwartz MG, Avrutin A, Bartel DP, Ulitsky I. Principles of long noncoding RNA evolution derived from direct comparison of transcriptomes in 17 species. Cell Rep. 2015; 11: 1110-1122. doi: 10.1016/j.celrep.2015.04.023
134. Diederichs S. The four dimensions of noncoding RNA conservation. Trends Genet. 2014; 30: 121-123. doi: 10.1016/j.tig.2014.01.004
135. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009; 458: 223-227. doi: 10.1038/nature07672
136. Nitsche A, Rose D, Fasold M, Reiche K, Stadler PF. Comparison of splice sites reveals that long noncoding RNAs are evolutionarily well conserved. 2015: 1-12. doi: 10.1261/rna.046342.114.studies
137. Washietl S, Kellis M, Garber M. Evolutionary dynamics and tissue specificity of human long noncoding RNAs in six mammals. 2014: 616-628. doi: 10.1101/gr.165035.113
138. Necsulea A, Soumillon M, Warnefors M, Liechti A, Daish T, Zeller U, Baker JC, Grützner F, Kaessmann H. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature. 2014; 505: 635-640. doi: 10.1038/nature12943
139. Hamlin RL, Altschuld RA. Extrapolation from mouse to man. Circ Cardiovasc Imaging. 2011; 4: 2-4. doi: 10.1161/CIRCIMAGING. 110.961979
140. Dorn GW II. LIPCAR: a mitochondrial lnc in the noncoding RNA chain?. Circ Res. 2014; 114: 1548-1550. doi: CIRCRESAHA.114.304028 [pii] 10.1161/CIRCRESAHA.114.304028
141. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 2013; 153: 910-918. doi: 10.1016/j.cell.2013.04.025
142. Gilbert L a, Horlbeck M a, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL. Genome-scale CRISPRmediated control of gene repression and activation. Cell. 2014; 159: 647-661. doi: 10.1016/j.cell.2014.09.029
143. Weeks KM, Mauger DM. Exploring RNA structural codes with SHAPE chemistry. Acc Chem Res. 2011; 44: 1280-1291. http://www.ncbi.nlm. nih.gov/pubmed/21615079
144. Novikova IV, Dharap A, Hennelly SP, Sanbonmatsu KY. 3S: shotgun secondary structure determination of long non-coding RNAs. Methods. 2013; 63: 170-177. http://www.ncbi.nlm.nih.gov/pubmed/23927838
145. Novikova I V, Hennelly SP, Sanbonmatsu KY. Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Nucleic Acids Res. 2012; 40: 5034-5051. http://www.ncbi.nlm.nih.gov/pubmed/22362738
146. Chu C, Spitale RC, Chang HY. Technologies to probe functions and mechanisms of long noncoding RNAs. Nat Publ Gr. 2015; 22: 29-35. doi: 10.1038/nsmb.2921
147. Greco S, Gorospe M, Martelli F. Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol. 2015; 83: 142-155. doi: 10.1016/j. yjmcc.2015.01.011
148. Boon RA, Iekushi K, Lechner S, et al. MicroRNA-34a regulates cardiac ageing and function. Nature. 2013; 495: 107-110. doi: 10.1038/nature11919